Hypnotic Medications and Memory: Effect of Drug Exposure During the Night

St. Luke's Hospital, Chesterfield, Missouri

Status and phase: Completed; Phase 4

Conditions: Memory; Sleep

Treatments: Drug: middle of the night placebo; Drug: zolpidem extended release; Drug: bedtime placebo; Drug: zaleplon

Study type: Interventional

Funder types: Other

Identifiers

NCT01159652

63-SR-10

Details and patient eligibility

About

The purpose of this study is to determine the effect of two hypnotic medications, zolpidem extended release and zaleplon, on memory. It is expected that a hypnotic with shorter drug duration will allow greater memory consolidation than a hypnotic with longer drug duration.

Full description

A growing body of evidence has demonstrated that sleep promotes memory consolidation in healthy individuals. However, little research has been conducted regarding the effect of hypnotics on sleep-dependent memory. One study found that zopiclone (7.5 mg), but not brotizolam (0.25 mg), impaired sleep-dependent memory consolidation in normal sleepers. Another study reported significant impairment of sleep-dependent memory on a motor task with triazolam (0.375 mg), but not with zolpidem immediate release (10 mg). These studies provide some evidence that sedative-hypnotic drugs may impair sleep-dependent memory consolidation, but further investigation is clearly needed in this area. Because hypnotics are commonly prescribed for insomnia, it is important to determine if there is a significant risk of impairment in sleep-dependent memory consolidation associated with these medications. Further, investigation of alternative doses and drug regimens upon memory consolidation appears warranted.

The purpose of the current study is to determine the effect of two hypnotic medications on sleep-dependent memory consolidation in normal sleepers. Zolpidem extended release, which will be active for most of the sleep period when administered at bedtime, will be compared to zaleplon, which will be active for half of the sleep period when administered in the middle of the night. This comparison allows us to address the question of whether a few hours of drug-free sleep results in better memory consolidation than sleep with drug throughout the night.

Enrollment: 26 patients

Sex: All

Ages: 18 to 50 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• 18 to 50 years of age
• no sleep complaints or problems
• good sleep quality per questionnaire
• sufficient time in bed each night

Exclusion criteria

• any clinically significant unstable medical condition
• recent psychiatric disorder
• prior diagnosis or symptoms of a sleep disorder
• recent history of substance abuse
• recent use of prescription hypnotic medication or over-the-counter sleep aid
• recent use of psychotropic medication
• history of adverse reaction to benzodiazepines
• body mass index > 36
• currently pregnant or nursing
• currently working rotating or night shift
• consumption of > 700 mg per day of xanthine-containing food or beverages
• consumption of > 14 units of alcohol per week
• smoke > 1 pack of cigarettes per day, use of chewing tobacco more than 3 times per day, or unable to refrain from smoking or chewing without distress or discomfort while in the sleep laboratory

Trial design

Primary purpose: Basic Science

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Double Blind

---

26 participants in 4 patient groups, including a placebo group

Bedtime Placebo

Placebo Comparator group

Treatment:

Drug: bedtime placebo

Middle of the Night Placebo

Placebo Comparator group

Treatment:

Drug: middle of the night placebo

Zolpidem

Experimental group

Treatment:

Drug: zolpidem extended release

Zaleplon

Experimental group

Treatment:

Drug: zaleplon